The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.EBI
Sanford-Burnham Medical Research Institute
Dual-Specificity Phosphatase CDC25A/B Inhibitor Identified from a Focused Library with Nonelectrophilic Core Structure.EBI
TBA
Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.EBI
Imperial College
Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis.EBI
Indiana University School of Medicine
Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids.EBI
Sanford-Burnham Medical Research Institute
Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages.EBI
University of Pittsburgh
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors.EBI
Eli Lilly
Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism.EBI
Purdue University
Highly Potent and Selective EBI
Purdue University
Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment.EBI
Chinese Academy of Sciences